Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Abécassis

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nature Communications|September 10, 2021
CloneSig can jointly infer intra-tumor heterogeneity and mutational signature activity in bulk tumor sequencing dataJudith Abécassis, Fabien Reyal, Jean-Philippe Vert
Annual Review of Biomedical Data Science|April 9, 2025
From Prediction to Prescription: Machine Learning and Causal Inference for the Heterogeneous Treatment EffectJudith Abécassis, Élise Dumas, Julie Alberge, et al.
Psychological Methods|April 9, 2026
Causal mediation analysis with one or multiple mediators: A comparative studyJudith Abécassis, Houssam Zenati, Sami Boumaïza, et al.
Plos One|November 8, 2019
Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing dataJudith Abécassis, Anne-Sophie Hamy, Cécile Laurent, et al.
Nature Communications|April 5, 2024
Concomitant medication, comorbidity and survival in patients with breast cancerElise Dumas, Beatriz Grandal Rejo, Paul Gougis, et al.
Eclinicalmedicine|August 8, 2025
Time-to-pregnancy in patients with previous breast cancer and unexposed women: a prospective exposed-unexposed cohort studyAnne-Sophie Hamy, Agathe Chabassier, Clara Sebbag, et al.
Nature Medicine|March 6, 2023
Evolution of synchronous female bilateral breast cancers and response to treatmentAnne-Sophie Hamy, Judith Abécassis, Keltouma Driouch, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nature Communications|September 10, 2021
CloneSig can jointly infer intra-tumor heterogeneity and mutational signature activity in bulk tumor sequencing dataJudith Abécassis, Fabien Reyal, Jean-Philippe Vert
Annual Review of Biomedical Data Science|April 9, 2025
From Prediction to Prescription: Machine Learning and Causal Inference for the Heterogeneous Treatment EffectJudith Abécassis, Élise Dumas, Julie Alberge, et al.
Psychological Methods|April 9, 2026
Causal mediation analysis with one or multiple mediators: A comparative studyJudith Abécassis, Houssam Zenati, Sami Boumaïza, et al.
Plos One|November 8, 2019
Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing dataJudith Abécassis, Anne-Sophie Hamy, Cécile Laurent, et al.
Nature Communications|April 5, 2024
Concomitant medication, comorbidity and survival in patients with breast cancerElise Dumas, Beatriz Grandal Rejo, Paul Gougis, et al.
Eclinicalmedicine|August 8, 2025
Time-to-pregnancy in patients with previous breast cancer and unexposed women: a prospective exposed-unexposed cohort studyAnne-Sophie Hamy, Agathe Chabassier, Clara Sebbag, et al.
Nature Medicine|March 6, 2023
Evolution of synchronous female bilateral breast cancers and response to treatmentAnne-Sophie Hamy, Judith Abécassis, Keltouma Driouch, et al.
Pageof 1